Literature DB >> 11011064

Molecular mechanisms regulating the retrograde axonal transport of neurotrophins.

A J Reynolds1, S E Bartlett, I A Hendry.   

Abstract

Neurotrophins are released from target tissues following neural innervation and bind to specific receptors situated on the nerve terminal plasma membrane. The neurotrophin-receptor complex undergoes retrograde axonal transport towards the cell soma, where it signals to the nucleus. This process allows neurotrophins to perform their numerous functions, which include the promotion of neuronal survival and the outgrowth of axons towards certain target tissues. The molecular events controlling each of the components of retrograde axonal transport are beginning to become defined. There is good evidence for the participation of phosphatidylinositol 3-kinase, phosphatidylinositol 4-kinase and the actin cytoskeleton in neurotrophin retrograde axonal transport in vivo. It also appears that the retrograde motor protein dynein mediates the retrograde axonal transport in vivo of neurotrophins such as nerve growth factor. This review discusses the role of the neurotrophin receptors in binding and axonal transport, the endocytic processes required for neurotrophin internalization, the targeting and trafficking of neurotrophins, and the propagation of neurotrophin-induced signals along the axon.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11011064     DOI: 10.1016/s0165-0173(00)00028-x

Source DB:  PubMed          Journal:  Brain Res Brain Res Rev


  20 in total

1.  Trafficking of TrkA-green fluorescent protein chimerae during nerve growth factor-induced differentiation.

Authors:  Jérôme Jullien; Vincent Guili; Edmund A Derrington; Jean-Luc Darlix; Louis F Reichardt; Brian B Rudkin
Journal:  J Biol Chem       Date:  2002-11-15       Impact factor: 5.157

2.  Retrograde axonal transport of dopamine beta hydroxylase antibodies by neurons in the trigeminal ganglion.

Authors:  Anna J Reynolds; Selma K Kaasinen; Ian A Hendry
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

3.  Axon and muscle spindle hyperplasia in the myostatin null mouse.

Authors:  Mohamed I Elashry; Anthony Otto; Antonios Matsakas; Salah E El-Morsy; Lisa Jones; Bethan Anderson; Ketan Patel
Journal:  J Anat       Date:  2011-02       Impact factor: 2.610

4.  Molecular mechanism of interleukin-2-induced mucosal homeostasis.

Authors:  Jayshree Mishra; Christopher M Waters; Narendra Kumar
Journal:  Am J Physiol Cell Physiol       Date:  2011-11-23       Impact factor: 4.249

Review 5.  Functional consequences of repeated organophosphate exposure: potential non-cholinergic mechanisms.

Authors:  A V Terry
Journal:  Pharmacol Ther       Date:  2012-03-20       Impact factor: 12.310

6.  Activation of 5-HT1A Receptors Promotes Retinal Ganglion Cell Function by Inhibiting the cAMP-PKA Pathway to Modulate Presynaptic GABA Release in Chronic Glaucoma.

Authors:  Xujiao Zhou; Rong Zhang; Shenghai Zhang; Jihong Wu; Xinghuai Sun
Journal:  J Neurosci       Date:  2018-12-12       Impact factor: 6.167

7.  A bi-directional carboxypeptidase E-driven transport mechanism controls BDNF vesicle homeostasis in hippocampal neurons.

Authors:  Joshua J Park; Niamh X Cawley; Y Peng Loh
Journal:  Mol Cell Neurosci       Date:  2008-06-04       Impact factor: 4.314

8.  Temporal and regional changes in IGF-1/IGF-1R signaling in the mouse brain after traumatic brain injury.

Authors:  Sindhu Kizhakke Madathil; Heather N Evans; Kathryn E Saatman
Journal:  J Neurotrauma       Date:  2010-01       Impact factor: 5.269

9.  Molecular kinetics of nerve growth factor receptor trafficking and activation.

Authors:  Jérôme Jullien; Vincent Guili; Louis F Reichardt; Brian B Rudkin
Journal:  J Biol Chem       Date:  2002-06-07       Impact factor: 5.157

10.  Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response.

Authors:  M-L Wong; C Dong; J Maestre-Mesa; J Licinio
Journal:  Mol Psychiatry       Date:  2008-05-27       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.